Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

FTRE

+ Watchlist+ Portfolio

Fortrea Holdings Inc.

Regulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$19.59
52-Week Range
$8.55 – $26.16
Market Cap
$1.98B
P/E (TTM)
—
EPS (TTM)
-0.73
Dividend Yield
0.00%
Advanced Metrics
Price/Book
3.72
PEG Ratio
0.34
Return on Equity
-12.34%
Return on Assets
1.03%
Gross Margin
20.00%
Operating Margin
1.70%
Profit Margin
-2.58%
Current Ratio
0.97
Debt/Equity
2.10
Total Debt
$1.12B
Free Cash Flow
$250.69M
Revenue Growth
-1.40%
Earnings Growth
—
Enterprise Value
$2.88B

Market Snapshot

About

Fortrea Holdings Inc. is a global contract research organization (CRO) providing clinical development and patient access services to biopharmaceutical and medical device companies. The company offers a comprehensive suite of services spanning Phase I through Phase IV clinical trials, including clinical trial management, data management, biostatistics, regulatory affairs, and medical writing. Fortrea was spun off from Labcorp in 2023 as a standalone publicly traded company. The company operates across multiple therapeutic areas and maintains a global presence with facilities and operations in numerous countries. Fortrea serves pharmaceutical and biotech companies of all sizes, from emerging biotechs to large multinational corporations.